carbamazepine has been researched along with Diplopia in 44 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Diplopia: A visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate and compare the effects of concomitant lamotrigine (LTG) or carbamazepine (CBZ) on the incidence of treatment-emergent adverse events (TEAEs) in patients taking adjunctive eslicarbazepine acetate (ESL) for focal (partial-onset) seizures (FS)." | 9.27 | Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures. ( Abou-Khalil, B; Blum, D; Cheng, H; Gama, H; Grinnell, T; Jung, J; Klein, P; Rocha, F; Ryvlin, P; Shah, A; Specchio, LM, 2018) |
| "This multicenter trial examined the efficacy and safety of oxcarbazepine in the treatment of bipolar disorder in children and adolescents." | 9.12 | A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. ( Berv, D; D'Souza, J; Emslie, GJ; Findling, RL; Kowatch, RA; Lehman, RB; Linden, D; McCague, K; Wagner, KD; Wamil, A; Wilens, TE, 2006) |
| "Nine cases of multiple sclerosis with paroxysmal disorders were treated with acetazolamide." | 7.65 | Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis. ( Alecu, C; Pruskauer-Apostol, B; Voiculescu, V, 1975) |
| "This study aimed to develop a pharmacokinetic (PK) model of oxcarbazepine (OXC) and analyse the relationship between monohydroxylated derivative (MHD), an active metabolite of OXC, and the adverse events of OXC." | 5.62 | Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy. ( Chu, K; Jang, IJ; Jang, Y; Kim, TJ; Lee, S; Lee, SK; Yoon, S; Yu, KS, 2021) |
| "To evaluate and compare the effects of concomitant lamotrigine (LTG) or carbamazepine (CBZ) on the incidence of treatment-emergent adverse events (TEAEs) in patients taking adjunctive eslicarbazepine acetate (ESL) for focal (partial-onset) seizures (FS)." | 5.27 | Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures. ( Abou-Khalil, B; Blum, D; Cheng, H; Gama, H; Grinnell, T; Jung, J; Klein, P; Rocha, F; Ryvlin, P; Shah, A; Specchio, LM, 2018) |
| "This multicenter trial examined the efficacy and safety of oxcarbazepine in the treatment of bipolar disorder in children and adolescents." | 5.12 | A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. ( Berv, D; D'Souza, J; Emslie, GJ; Findling, RL; Kowatch, RA; Lehman, RB; Linden, D; McCague, K; Wagner, KD; Wamil, A; Wilens, TE, 2006) |
| " We report a case of a patient post-kidney transplant who was on regular carbamazepine for childhood epilepsy and developed nystagmus, diplopia and a broad-base gait after receiving diltiazem." | 4.12 | Lessons of the month 2: A case of inappropriate drug-drug interaction in kidney transplant. ( Tan, MH; Yahya, R; Yee, SY, 2022) |
| "A 72-year-old man with chronic arachnoiditis following myelography with thorium dioxide (Thorotrast) developed intermittent diplopia and a partial right third nerve palsy." | 3.69 | Intermittent diplopia and strabismus caused by ocular neuromyotonia. ( Azzarelli, B; Nelson, PB; Purvin, VA; Yee, RD, 1996) |
| "Nine cases of multiple sclerosis with paroxysmal disorders were treated with acetazolamide." | 3.65 | Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis. ( Alecu, C; Pruskauer-Apostol, B; Voiculescu, V, 1975) |
| "Two patients with intractable epilepsy who had been treated with various combinations of anticonvulsant drugs developed phenytoin encephalopathy." | 3.65 | Choreo-athetosis and encephalopathy induced by phenytoin. ( McLellan, DL; Swash, M, 1974) |
| "Treatment with carbamazepine remains first-line therapy, although other membrane stabilizing agents and surgical interventions can be effective." | 2.82 | Ocular neuromyotonia: a review of diagnosis and treatment. ( Lee, MS; Lee, SK, 2022) |
| "Analysis of overall tolerability and neurological adverse effects (AEs) of eslicarbazepine acetate (ESL), lacosamide (LCM) and oxcarbazepine (OXC) from double-blind, placebo-controlled trials." | 2.49 | Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine. ( Fadda, V; Giovannelli, F; Maratea, D; Verrotti, A; Zaccara, G, 2013) |
| "Ocular neuromyotonia (ONM) is a rare neurogenic disorder of ocular motility." | 2.45 | [Ocular neuromyotonia--clinical appearance and thoughts on pathogenesis]. ( Salchow, D; Wermund, TK, 2009) |
| "The characteristic symptoms of ocular neuromyotonia and the typical history of a previous intracranial tumor, treated neurosurgically with adjuvant radiotherapy, lead to the hypothesis that ephaptic transmission in the cranial nerve is the underlying pathophysiological mechanism in the development of ocular neuromyotonia." | 2.43 | [Ocular neuromyotonia]. ( Gräf, M; Koop, G, 2006) |
| "This study aimed to develop a pharmacokinetic (PK) model of oxcarbazepine (OXC) and analyse the relationship between monohydroxylated derivative (MHD), an active metabolite of OXC, and the adverse events of OXC." | 1.62 | Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy. ( Chu, K; Jang, IJ; Jang, Y; Kim, TJ; Lee, S; Lee, SK; Yoon, S; Yu, KS, 2021) |
| "Ocular neuromyotonia is an unusual condition in which sustained, undesired contraction of one or more extraocular muscles occurs after normal muscle activation." | 1.39 | Partial third nerve palsy and ocular neuromyotonia from displacement of posterior communicating artery detected by high-resolution MRI. ( Blitz, AM; Cruz, FM; Subramanian, PS, 2013) |
| "Ocular neuromyotonia is an episodic involuntary contraction of one or more of the extraocular muscles resulting from spontaneous neural discharges of the oculomotor nerve." | 1.39 | Oculomotor neuromyotonia with lid ptosis on abduction. ( Chang, MH; Kim, SB; Kyung, SE; Oh, SY, 2013) |
| "Ocular neuromyotonia is a rare disturbance of ocular motility, characterized by paroxysmal monocular involuntary spasms of one or more extraocular muscles supplied by the third, fourth or sixth cranial nerves." | 1.34 | [Case of ocular neuromyotonia with transient and gaze-induced diplopia]. ( Hayashi, H; Isozaki, E; Kuroda, M; Matsubara, S; Yoshida, H, 2007) |
| "Ocular neuromyotonia is a rare clinical entity, which is characterized by spontaneous spasm of ocular muscles resulting in paroxysmal diplopia and strabismus." | 1.32 | Ocular neuromyotonia: a case report. ( Ilhan, S; Yürüten, B, 2003) |
| "Intermittent diplopia developed several years after myelography with thorium dioxide (Thorotrast), radiation treatment for a pituitary tumor, and radiotherapy for medulloblastoma of the posterior fossa." | 1.30 | Ocular neuromyotonia: three case reports with eye movement recordings. ( Purvin, VA; Yee, RD, 1998) |
| "05) change in the serum concentrations of either CBZ or its epoxide metabolite when LTG was added either to the group as a whole or to the nine patients who experienced adverse CNS effects." | 1.30 | Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction? ( Berry, DJ; Besag, FM; Newbery, JE; Pool, F; Subel, B, 1998) |
| "Six patients (18%) developed psychiatric disorders." | 1.29 | Psychiatric disorders in patients with Fabry's disease. ( Grewal, RP, 1993) |
| "She presented with paroxysmal diplopia and the clinical findings were consistent with ocular neuromyotonia." | 1.29 | Ocular neuromyotonia--an unusual ocular motility complication after radiation therapy for nasopharyngeal carcinoma. ( Fu, ER, 1995) |
| "Side effects (particularly diplopia and nystagmus) were observed in five patients and showed an intermittent pattern in four." | 1.27 | Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects. ( Albani, F; Ambrosetto, G; Baruzzi, A; Contin, M; Cortelli, P; Perucca, E; Riva, R, 1984) |
| "Paroxysmal dysarthria and ataxia (7 cases), and tonic seizures (5 cases) were the most common types of attacks." | 1.25 | Paroxysmal attacks in multiple sclerosis. ( Ostermann, PO; Westerberg, CE, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (20.45) | 18.7374 |
| 1990's | 10 (22.73) | 18.2507 |
| 2000's | 11 (25.00) | 29.6817 |
| 2010's | 11 (25.00) | 24.3611 |
| 2020's | 3 (6.82) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, MH | 1 |
| Yee, SY | 1 |
| Yahya, R | 1 |
| Lee, SK | 2 |
| Lee, MS | 1 |
| Jang, Y | 1 |
| Yoon, S | 1 |
| Kim, TJ | 1 |
| Lee, S | 1 |
| Yu, KS | 1 |
| Jang, IJ | 1 |
| Chu, K | 1 |
| Androsova, G | 1 |
| Krause, R | 1 |
| Borghei, M | 1 |
| Wassenaar, M | 1 |
| Auce, P | 1 |
| Avbersek, A | 1 |
| Becker, F | 1 |
| Berghuis, B | 1 |
| Campbell, E | 1 |
| Coppola, A | 1 |
| Francis, B | 1 |
| Wolking, S | 1 |
| Cavalleri, GL | 1 |
| Craig, J | 1 |
| Delanty, N | 1 |
| Koeleman, BPC | 1 |
| Kunz, WS | 1 |
| Lerche, H | 1 |
| Marson, AG | 1 |
| Sander, JW | 1 |
| Sills, GJ | 1 |
| Striano, P | 1 |
| Zara, F | 1 |
| Sisodiya, SM | 1 |
| Depondt, C | 1 |
| Joosten, IBT | 1 |
| Hoeijmakers, JGJ | 1 |
| Abou-Khalil, B | 1 |
| Klein, P | 1 |
| Shah, A | 1 |
| Ryvlin, P | 1 |
| Specchio, LM | 1 |
| Gama, H | 1 |
| Rocha, F | 1 |
| Blum, D | 1 |
| Grinnell, T | 1 |
| Cheng, H | 1 |
| Jung, J | 1 |
| Grosinger, A | 1 |
| Chen, JJ | 1 |
| Bhatti, MT | 1 |
| Zaccara, G | 1 |
| Giovannelli, F | 1 |
| Maratea, D | 1 |
| Fadda, V | 1 |
| Verrotti, A | 1 |
| Roper-Hall, G | 1 |
| Cruz, OA | 1 |
| Espinoza, GM | 1 |
| Chung, SM | 1 |
| Cruz, FM | 1 |
| Blitz, AM | 1 |
| Subramanian, PS | 1 |
| Wermund, TK | 1 |
| Salchow, D | 1 |
| Weston, K | 1 |
| Bush, K | 1 |
| Afshar, F | 1 |
| Rowley, S | 1 |
| Della Marca, G | 1 |
| Frisullo, G | 1 |
| Vollono, C | 1 |
| Dittoni, S | 1 |
| Losurdo, A | 1 |
| Testani, E | 1 |
| Colicchio, S | 1 |
| Gnoni, V | 1 |
| Rizzo, D | 1 |
| Riccardi, R | 1 |
| Batocchi, AP | 1 |
| Inoue, T | 1 |
| Hirai, H | 1 |
| Shimizu, T | 1 |
| Tsuji, M | 1 |
| Shima, A | 1 |
| Suzuki, F | 1 |
| Matsuda, M | 1 |
| Kim, SB | 1 |
| Oh, SY | 1 |
| Chang, MH | 1 |
| Kyung, SE | 1 |
| Yürüten, B | 1 |
| Ilhan, S | 1 |
| Duman, O | 1 |
| Balta, G | 1 |
| Metinsoy, M | 1 |
| Haspolat, S | 1 |
| Webster, R | 1 |
| Leslie, S | 1 |
| Banks, MC | 1 |
| Caruso, PA | 1 |
| Lessell, S | 1 |
| Versino, M | 1 |
| Colnaghi, S | 1 |
| Todeschini, A | 1 |
| Candeloro, E | 1 |
| Ravaglia, S | 1 |
| Moglia, A | 1 |
| Cosi, V | 1 |
| Koop, G | 1 |
| Gräf, M | 1 |
| Jacob, M | 1 |
| Vighetto, A | 1 |
| Bernard, M | 1 |
| Tilikete, C | 1 |
| Wagner, KD | 1 |
| Kowatch, RA | 1 |
| Emslie, GJ | 1 |
| Findling, RL | 1 |
| Wilens, TE | 1 |
| McCague, K | 1 |
| D'Souza, J | 1 |
| Wamil, A | 1 |
| Lehman, RB | 1 |
| Berv, D | 1 |
| Linden, D | 1 |
| Williams, PE | 1 |
| Purvin, VA | 3 |
| Kawasaki, A | 1 |
| Kuroda, M | 1 |
| Isozaki, E | 1 |
| Matsubara, S | 1 |
| Yoshida, H | 1 |
| Hayashi, H | 1 |
| Livingston, S | 1 |
| Pauli, LL | 1 |
| Berman, W | 1 |
| Riva, R | 1 |
| Albani, F | 1 |
| Ambrosetto, G | 1 |
| Contin, M | 1 |
| Cortelli, P | 1 |
| Perucca, E | 1 |
| Baruzzi, A | 1 |
| Frens, DB | 1 |
| Frohman, EM | 1 |
| Zee, DS | 1 |
| Jauhari, J | 1 |
| Jauhari, S | 1 |
| Grewal, RP | 1 |
| Fu, ER | 1 |
| Yee, RD | 2 |
| Azzarelli, B | 1 |
| Nelson, PB | 1 |
| Fukuo, Y | 1 |
| Abe, T | 1 |
| Hayasaka, S | 1 |
| Besag, FM | 1 |
| Berry, DJ | 1 |
| Pool, F | 1 |
| Newbery, JE | 1 |
| Subel, B | 1 |
| López, L | 1 |
| Thomson, A | 1 |
| Rabinowicz, AL | 1 |
| Ostermann, PO | 1 |
| Westerberg, CE | 1 |
| Voiculescu, V | 1 |
| Pruskauer-Apostol, B | 1 |
| Alecu, C | 1 |
| ten Berg, JM | 1 |
| de Waal, WJ | 1 |
| Mauser, HW | 1 |
| McLellan, DL | 1 |
| Swash, M | 1 |
| Hermans, G | 1 |
| Susac, JO | 1 |
| Smith, JL | 1 |
| Schatz, NJ | 1 |
| Ricker, K | 1 |
| Mertens, HG | 1 |
4 reviews available for carbamazepine and Diplopia
| Article | Year |
|---|---|
Ocular neuromyotonia: a review of diagnosis and treatment.
Topics: Adult; Carbamazepine; Child; Diplopia; Excipients; Humans; Isaacs Syndrome; Ocular Motility Disorder | 2022 |
Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Topics: Acetamides; Anticonvulsants; Ataxia; Carbamazepine; Dibenzazepines; Diplopia; Dizziness; Dose-Respon | 2013 |
[Ocular neuromyotonia--clinical appearance and thoughts on pathogenesis].
Topics: Animals; Anticonvulsants; Axons; Carbamazepine; Diplopia; Electromyography; Interneurons; Isaacs Syn | 2009 |
[Ocular neuromyotonia].
Topics: Abducens Nerve Diseases; Carbamazepine; Combined Modality Therapy; Diplopia; Female; Humans; Isaacs | 2006 |
2 trials available for carbamazepine and Diplopia
| Article | Year |
|---|---|
Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Dibenzazepines; Diplopia; Dose-Response Re | 2018 |
A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
Topics: Adolescent; Age Factors; Ambulatory Care; Anticonvulsants; Bipolar Disorder; Carbamazepine; Child; D | 2006 |
38 other studies available for carbamazepine and Diplopia
| Article | Year |
|---|---|
Lessons of the month 2: A case of inappropriate drug-drug interaction in kidney transplant.
Topics: Anticonvulsants; Carbamazepine; Child; Diltiazem; Diplopia; Drug Interactions; Gait; Gait Disorders, | 2022 |
Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Diplopia; Dizziness; Dru | 2021 |
Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.
Topics: Adolescent; Adult; Aged; Amines; Anticonvulsants; Ataxia; Benzodiazepines; Carbamazepine; Clobazam; | 2017 |
Mystery Case: Superior oblique myokymia: An uncommon cause of intermittent diplopia.
Topics: Adult; Anticonvulsants; Carbamazepine; Diplopia; Humans; Magnetic Resonance Imaging; Male; Trochlear | 2018 |
Gaze-Provoked Exotropia in a Young Woman.
Topics: Abducens Nerve Diseases; Adult; Carbamazepine; Diplopia; Exotropia; Eye Movements; Female; Fixation, | 2019 |
Cyclic (alternate day) vertical deviation--possible forme fruste of ocular neuromyotonia.
Topics: Carbamazepine; Diplopia; Exophthalmos; Female; Humans; Isaacs Syndrome; Male; Middle Aged; Oculomoto | 2013 |
Partial third nerve palsy and ocular neuromyotonia from displacement of posterior communicating artery detected by high-resolution MRI.
Topics: Aged; Anticonvulsants; Carbamazepine; Circle of Willis; Diplopia; Female; Humans; Isaacs Syndrome; M | 2013 |
Can he fix it? Yes, he can!
Topics: Aged; Anticonvulsants; Carbamazepine; Diplopia; Eye Protective Devices; Female; Humans; Isaacs Syndr | 2010 |
Oculogyric crisis in a midbrain lesion.
Topics: Anti-Inflammatory Agents; Anticonvulsants; Biopsy; Carbamazepine; Cerebral Arteries; Diagnosis, Diff | 2011 |
Ocular neuromyotonia treated by microvascular decompression: usefulness of preoperative 3D imaging: case report.
Topics: Anticonvulsants; Carbamazepine; Diplopia; Female; Humans; Imaging, Three-Dimensional; Microvascular | 2012 |
Oculomotor neuromyotonia with lid ptosis on abduction.
Topics: Analgesics, Non-Narcotic; Blepharoptosis; Carbamazepine; Diplopia; Humans; Isaacs Syndrome; Male; Mi | 2013 |
Ocular neuromyotonia: a case report.
Topics: Adult; Anticonvulsants; Carbamazepine; Diplopia; Female; Humans; Isaacs Syndrome; Oculomotor Nerve D | 2003 |
Unusual manifestation of subacute sclerosing panencephalitis: case with intracranial high-pressure symptoms.
Topics: Anticonvulsants; Brain; Carbamazepine; Child, Preschool; Diplopia; Female; Fructose; Humans; Intracr | 2004 |
Earlier report of superior oblique myokymia.
Topics: Carbamazepine; Diplopia; Humans; Myokymia; Oculomotor Muscles | 2004 |
Midbrain-thalamic ocular neuromyotonia.
Topics: Adult; Anticonvulsants; Carbamazepine; Diplopia; Dizziness; Humans; Isaacs Syndrome; Magnetic Resona | 2005 |
Ocular neuromyotonia with both tonic and paroxysmal components due to vascular compression.
Topics: Anticonvulsants; Carbamazepine; Diplopia; Female; Functional Laterality; Humans; Magnetic Resonance | 2005 |
Ocular neuromyotonia secondary to a cavernous sinus meningioma.
Topics: Acetazolamide; Adult; Carbamazepine; Cavernous Sinus; Clonazepam; Diplopia; Esotropia; Female; Human | 2006 |
Superior oblique myokymia: efficacy of medical treatment.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Diplopia; Drug Therapy, Combination; Female | 2007 |
[Case of ocular neuromyotonia with transient and gaze-induced diplopia].
Topics: Aged; Carbamazepine; Diplopia; Fixation, Ocular; Humans; Isaacs Syndrome; Male; Ocular Motility Diso | 2007 |
Carbamazepine (Tegretol) in epilepsy. Nine year follow-up study with special emphasis on untoward reactions.
Topics: Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Carbamazepine; Child; Diplopia; Drug Overd | 1974 |
Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects.
Topics: Adolescent; Adult; Carbamazepine; Child; Circadian Rhythm; Diplopia; Female; Humans; Male; Middle Ag | 1984 |
Superior oblique myokymia: a treatable cause of monocular diplopia.
Topics: Adult; Carbamazepine; Diplopia; Female; Humans; Nystagmus, Pathologic; Oculomotor Muscles; Syndrome; | 1980 |
Ocular neuromyotonia: clinical features, physiological mechanisms, and response to therapy.
Topics: Aged; Carbamazepine; Diplopia; Humans; Male; Neuromuscular Diseases; Oculomotor Muscles; Saccades | 1995 |
Mazetal, diplopia and epilepsy.
Topics: Carbamazepine; Diplopia; Epilepsy; Humans | 1994 |
Psychiatric disorders in patients with Fabry's disease.
Topics: Adult; alpha-Galactosidase; Carbamazepine; Cerebrovascular Disorders; Diplopia; Fabry Disease; Human | 1993 |
Ocular neuromyotonia--an unusual ocular motility complication after radiation therapy for nasopharyngeal carcinoma.
Topics: Abducens Nerve; Administration, Oral; Carbamazepine; Carcinoma; Central Nervous System Agents; Cobal | 1995 |
Intermittent diplopia and strabismus caused by ocular neuromyotonia.
Topics: Aged; Analgesics, Non-Narcotic; Arachnoiditis; Carbamazepine; Carcinogens; Diagnosis, Differential; | 1996 |
Acute comitant esotropia in a boy with head trauma and convulsions receiving carbamazepine.
Topics: Acute Disease; Anticonvulsants; Carbamazepine; Child; Diplopia; Dose-Response Relationship, Drug; Es | 1998 |
Ocular neuromyotonia: three case reports with eye movement recordings.
Topics: Aged; Anticonvulsants; Brain Neoplasms; Carbamazepine; Diplopia; Electrooculography; Eye Movements; | 1998 |
Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?
Topics: Anticonvulsants; Carbamazepine; Child; Diplopia; Dizziness; Dose-Response Relationship, Drug; Drug A | 1998 |
Assessment of colour vision in epileptic patients exposed to single-drug therapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Color Perception; Color Vision Defects; Dip | 1999 |
Paroxysmal attacks in multiple sclerosis.
Topics: Adult; Ataxia; Carbamazepine; Diplopia; Female; Functional Laterality; Humans; Hypesthesia; Male; Mi | 1975 |
Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis.
Topics: Acetazolamide; Adult; Aged; Brain Stem; Carbamazepine; Diplopia; Female; Humans; Hypesthesia; Male; | 1975 |
[Paroxysmal symptoms as initial expression of multiple sclerosis].
Topics: Adult; Carbamazepine; Diplopia; Dysarthria; Female; Gait; Humans; Multiple Sclerosis; Muscle Cramp; | 1992 |
Choreo-athetosis and encephalopathy induced by phenytoin.
Topics: Adolescent; Adult; Ataxia; Athetosis; Carbamazepine; Chorea; Diplopia; Electroencephalography; Epile | 1974 |
[Harmful effects of common drugs on the visual apparatus. Anticonvulsants].
Topics: Anticonvulsants; Barbiturates; Carbamazepine; Color Vision Defects; Diplopia; Eye Diseases; Humans; | 1972 |
Superior oblique myokymia.
Topics: Adolescent; Adult; Carbamazepine; Diplopia; Eye Movements; Female; Humans; Male; Middle Aged; Muscul | 1973 |
[Ocular neuromyotony].
Topics: Adult; Carbamazepine; Diagnosis, Differential; Dibenzazepines; Diplopia; Electromyography; Female; H | 1970 |